ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2310건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1568 | Unknown status | Dendritic Cell Vaccine to Prevent COVID-19 | COVID-19 | Biological: AV-COVID-19 | Phase 1 | Indonesia-MoH, Aivita Biomedical, Inc., PT AIVITA Biomedika Indonesia, National Institute of Health Research and Development, Ministry of Health Republic of Indonesia, RSUP Dr. Kariadi Semarang, indonesia, Faculty of Medicine University of Diponegoro, Indonesia | OTHER_GOV | 27 | All | 18 Years | Rumah Sakit Umum Pusat Dr. Kariadi, Semarang, Jawa Tengah, Indonesia |
| 1567 | Completed | Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection | COVID-19 | Biological: AV-COVID-19 Other: GM-CSF |
Phase 1 | Aivita Biomedical, Inc., PT AIVITA Biomedika Indonesia, Indonesia Ministry of Health, National Institute of Health Research and Development, Ministry of Health Republic of Indonesia | INDUSTRY | 27 | All | 18 Years | Rumah Sakit Umum Pusat Dr. Kariadi, Semarang, Jawa Tengah, Indonesia |
| 1566 | Completed | Desidustat in the Management of COVID-19 Patients | COVID-19 | Drug: Desidustat Other: Standard of Care |
Phase 2 | Zydus Lifesciences Limited | INDUSTRY | 24 | All | 18 Years | Avant Sante Site 1, Monterrey, Mexico |
| 1565 | Recruiting | Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT | Covid19 Pneumonia | Drug: [18F]FP-R01-MG-F2 | Early Phase 1 | Stanford University, Pliant Therapeutics, Inc. | OTHER | 30 | All | 18 Years | Stanford University, Stanford, California, United States |
| 1564 | Unknown status | Determining Reactogenicity and Immunogenicity of Delayed COVID-19 Vaccine Schedule in Children | Children, Only | Biological: BNT162b2 Pfizer-BioNTech/Comirnaty | Phase 4 | KK Women's and Children's Hospital, Duke-NUS Graduate Medical School | OTHER_GOV | 150 | All | 5 Years ~ 11 Years | KK Women's and Children's Hospital, Bukit Timah, Singapore |
| 1563 | Unknown status | Development and Validation of "Ready-to-Use" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19 | Hydroxychloroquine Adverse Reaction | Drug: inhalable hydroxychloroquine (HCQ) Drug: supportive and symptomatic treatment |
Not Applicable | Mansoura University | OTHER | 40 | All | 18 Years | Mansoura University Hospital, Mansoura, Outside U.S./Canada, Egypt |
| 1562 | Unknown status | Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia | COVID-19 | Drug: Dexamethasone injection Drug: placebo Procedure: conventional oxygen Procedure: CPAP Procedure: HFNO Procedure: mechanical ventilation |
Not Applicable | Assistance Publique - Hopitaux de Paris | OTHER | 550 | All | 18 Years | Hopital Bichat - Aphp, Paris, France |
